Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-19

Clinical Trial Update: A Study of LY2881835 in Healthy People and People With Diabetes [Phase 1]

View source ↗

Summary

Phase 1 trial update for LY2881835 in healthy individuals and people with type 2 diabetes; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY2881835 (LY2881835)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2019-06-19